Section Arrow
Quote
RFL.NYSE
- Rafael Holdings
Quotes are at least 15-min delayed:2025/12/26 19:52 EST
Regular Hours
Last
 1.2
+0.02 (+1.69%)
Day High 
1.29 
Prev. Close
1.18 
1-M High
1.6 
Volume 
87.76K 
Bid
1.16
Ask
1.2
Day Low
1.16 
Open
1.169 
1-M Low
1.15 
Market Cap 
61.08M 
Currency 美元 
P/E 14.3 
%Yield -- 
10-SMA 1.27 
20-SMA 1.28 
50-SMA 1.3 
52-W High 3.19 
52-W Low 1.15 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
-0.87/--
Enterprise Value
61.16M
Balance Sheet
Book Value Per Share
1.65
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
917.00K
Operating Revenue Per Share
0.01
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
OPENOpendoor Technologies6.01-0.27-4.30%-- 
AIREreAlpha Tech Corp0.4649+0.012+2.65%-- 
COMPCompass10.59-0.09-0.84%-- 
BEKEKE Holdings16.22+0.18+1.12%37.96PE
CSGPCoStar Group67.01+0.12+0.18%1,114.83PE
Industry overview quotes are at least 15 minutes delayed
Business Description
Rafael Holdings Inc is a biotechnology firm that develops pharmaceuticals and invests in clinical and early-stage companies in pharmaceuticals and medical devices. Trappsol Cyclo is in Phase 3 trials for Niemann-Pick Disease Type C1. The company focuses on completing these trials, seeking regulatory approval, and commercializing the product. It also invests in portfolio companies including Cyclo, LipoMedix, Barer, Rafael Medical Devices, Cornerstone, and Day Three, targetingtherapeutics for unmet medical needs. The business operates through three segments: Healthcare, Infusion Technology, and Real Estate. Operations are based in the United States and Israel.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.